Evidence map›Paper›PMID 35994695›Full record

ReviewJCO global oncology2022

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.

Christian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, Andrés Cardona, Jorge Sapunar, Fred R Hirsch, David R Gandara, Gilberto Morgan, Silvia Novello, Marina-Chiara Garassino and 19 more

Abstract readReview
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Enhancement of antitumor activity through structural optimization of 2-(Benzylamino)-thieno[2,3-d]pyrimidin-4(3H)-ones.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Provision of supportive care by an NGO in the face of a dual challenge: cancer and wartime.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Refugees have cancer too.Ecancermedicalscience · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Christian CaglevicCancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.ORCID 0000-0003-3319-1678
Christian RolfoClinical Research Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.ORCID 0000-0002-7860-8417
Ignacio Gil-BazoUniversidad de Navarra, Department of Oncology, Pamplona, Spain.ORCID 0000-0002-2626-5109
Andrés CardonaLuis Carlos Sarmiento Angulo Cancer Treatment and Research Center-CTIC, ONCOLGroup/FICMAC, Bogota, Colombia.ORCID 0000-0003-3525-4126
Jorge SapunarCancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Fred R HirschCenter for Thoracic Oncology. Mount Sinai Cancer, Mount Sinai Health System, Icahn School of Medicine, Joe Lowe and Louis Price Professor of Medicine, Tisch Cancer Institute, New York, NY.ORCID 0000-0002-6885-1894
David R GandaraCenter for Experimental Therapeutics in Cancer, UC Davis Comprehensive Cancer Center, Translational and Clinical Research Program, University of Hawaii Cancer Center, International Society of Liquid Biopsy, Sacramento, CA.ORCID 0000-0003-1784-048X
Gilberto MorganSkåne University Hospital, Department of Oncology, Lund, Sweden.ORCID 0000-0002-6054-2384
Silvia NovelloOncology Department, AOU San Luigi, University of Turin, Turin, Italy.ORCID 0000-0001-7653-9748
Marina-Chiara GarassinoThoracic Oncology Program, the University of Chicago, Chicago, IL.ORCID 0000-0002-3821-5598
Giannis Mountzios4th Oncology Department and Clinical Trials Unit Henry Dunant Hospital Center, Athens, Greece.ORCID 0000-0002-7780-7836
Natasha B LeighlMedical Oncology Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, IHPME, Dalla Lana School of Public Health, Toronto, Canada.ORCID 0000-0002-3249-4602
Denisse BretelGECOPERU, Lima, Peru.ORCID 0000-0001-9851-1367
Oscar ArrietaToracic Oncology Unit, Instituto Nacional de Cancerologia de Mexico, Mexico City, Mexico.ORCID 0000-0002-1164-3779
Alfredo AddeoOncology department, University Hospital Geneva, Geneva, Switzerland.ORCID 0000-0003-0988-0828
Stephen V LiuLombardi Comprehensive Cancer Center of Georgetown University, Washington, DC.ORCID 0000-0002-4852-3914
Luis CorralesCentro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica.ORCID 0000-0001-9732-5693
Vivek SubbiahDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine, Medical Oncology Research, MD Anderson Cancer Network, Clinical Center For Targeted Therapy, Division of Pediatrics UT MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-6064-6837
Francisco AboitizCentro Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica, Santiago, Chile.
Franz Villarroel-EspindolaCancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.ORCID 0000-0003-0080-2444
Felipe Reyes-CosmelliClinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Ricardo MoralesCancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Mauricio MahaveCancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Luis RaezMemorial Cancer Institute/Memorial Health Care System, MCIFAU Florida Cancer Center of Excellence, Florida International University, Miami, FL.
Jorge AlatorreInstituto Nacional de Enfermedades Respiratorias (INER) Clínica de Oncología Torácica, México D.F., Mexico.
Edgardo SantosFlorida Precision Oncology/a Division of Genesis Care USA, Research Services Thoracic and Head/Neck Cancer Programs Clinical, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL.ORCID 0000-0003-0776-4903
Luis UbillosInstituto Nacional del Cancer, Montevideo, Uruguay.ORCID 0000-0002-9081-7545
Daniel S W TanDepartment of Medical Oncology, National Cancer Centre Singapore, Singapore.ORCID 0000-0002-6514-6786
Christoph ZielinskiCentral European Cancer Center, Wiener Privatklinik, Vienna, and Central European Cooperative Oncology Group, HQ, Vienna, Austria.ORCID 0000-0002-1440-9013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On February 24, 2022, a war began within the Ukrainian borders. At least 3.0 million Ukrainian inhabitants have already fled the country. Critical infrastructure, including hospitals, has been damaged. Children with cancer were urgently transported to foreign countries, in an effort to minimize interruption of their life-saving treatments. Most adults did not have that option. War breeds cancer-delaying diagnosis, preventing treatment, and increasing risk. We project that a modest delay in care of only 4 months for five prevalent types of cancer will lead to an excess of over 3,600 cancer deaths in the subsequent years. It is critical that we establish plans to mitigate that risk as soon as possible.

Indexed as

NeoplasmsResearchAdultArmed ConflictsChildHumansUkraine

Identifiers

PMID35994695
PMCPMC9470147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.